GILD
Gilead Sciences
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: GILD
- PEG Ratio
Gilead Sciences currently trades with a PEG ratio of 0.32, based on Jul 13, 2026 data. Dividing the 17.71 PE ratio by the 55.6% earnings growth rate produces this figure. Relative to the 0.1 average from the past four quarters, the PEG ratio has surged by 228%.
GILD PEG ratio history
Historically, Gilead Sciences has a PEG ratio averaging 1.09 across the last eight years. At 0.32, today's PEG ratio sits 71% less than its historical average. The eight years high came in the Dec 2019 quarter at 15.33, reflecting peak valuation relative to growth. The bottom was reached in the Dec 2021 quarter at 0, suggesting attractive value relative to growth during that period.
Gilead Sciences PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.01 | 17.94 | 1,700% |
| 2024 | N/A | 243.08 | -91.6% |
| 2023 | 0.74 | 17.84 | 24% |
| 2022 | N/A | 23.46 | -26.2% |
| 2021 | 0 | 14.64 | 4,860% |
| 2020 | N/A | 582.6 | -97.6% |
| 2019 | 15.33 | 15.33 | 1% |
| 2018 | 0.8 | 14.89 | 18.6% |
| 2017 | N/A | 20.24 | -64.9% |
| 2016 | N/A | 7.1 | -18.5% |
| 2015 | 0.15 | 8.18 | 55.6% |
| 2014 | 0.04 | 11.86 | 295.5% |
| 2013 | 2.13 | 37.36 | 17.5% |
| 2012 | N/A | 21.48 | -5.5% |
| 2011 | 1.59 | 11.31 | 7.1% |
Gilead Sciences PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.34 | 18.78 | 55.6% |
| Dec 2025 | 0.01 | 17.94 | 1,700% |
| Sep 2025 | 0 | 17.05 | 6,410% |
| Jun 2025 | 0.04 | 21.95 | 494.1% |
| Mar 2025 | 0.02 | 23.49 | 1,092.5% |
| Dec 2024 | N/A | 243.08 | -91.6% |
| Sep 2024 | N/A | 838.4 | -97.9% |
| Jun 2024 | N/A | 80.72 | -80.6% |
| Mar 2024 | N/A | 183.13 | -91% |
| Dec 2023 | 0.74 | 17.84 | 24% |
| Sep 2023 | 0.21 | 15.91 | 76.4% |
| Jun 2023 | 0.53 | 17.56 | 33% |
| Mar 2023 | 0.78 | 18.6 | 23.9% |
| Dec 2022 | N/A | 23.46 | -26.2% |
| Sep 2022 | N/A | 23.1 | -54.7% |
GILD average PEG ratio chart
When comparing to historical data, GILD's PEG ratio sits above the 3 and 5-year averages, but it is lower than the 10-year average.
PEG comparison
Gilead Sciences's PEG of 0.32 is higher than its peers average but lower than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 0.57, Gilead Sciences's PEG is 44% lower.
GILD EPS growth
GILD Price vs fair value
GILD PEG vs peers
Relative to its peers, GILD's PEG ratio is lower than LLY's and AMGN's yet above VRTX's and ILMN's. Gilead Sciences's PEG ratio of 0.32 is above the peer average of 0.29.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| VRTX Vertex Pharmaceuticals Inc | 0.05 | $121.89B |
| QGEN Qiagen NV | 0.07 | $8.57B |
| ILMN Illumina Inc | 0.18 | $28.75B |
| GILD Gilead Sciences Inc | 0.32 | $163.14B |
| LLY ELI LILLY & Co | 0.33 | $1.11T |
| AMGN Amgen Inc | 0.8 | $194.54B |
| ABBV AbbVie Inc | N/A | $438.16B |
| BIIB Biogen Inc | N/A | $30.86B |
| PFE Pfizer Inc | N/A | $139.52B |
| JNJ Johnson & Johnson | N/A | $620.51B |
| MRK Merck & Co Inc | N/A | $306.33B |
Frequently asked questions
What is Gilead Sciences's PEG ratio?
GILD's Jul 13, 2026 PEG ratio comes in at 0.32.
What is the 3-year average PEG ratio for Gilead Sciences (GILD)?
Across the past 3 years, GILD's PEG ratio has averaged at 0.19.
What is the 5-year average PEG ratio for Gilead Sciences (GILD)?
Across the past 5 years, GILD's PEG ratio has averaged at 0.23.
What is the highest PEG ratio for GILD?
In the last eight years, GILD's peak PEG ratio of 15.33 occurred in the Dec 2019 quarter.
How does the current PEG ratio for GILD compare to its historical average?
Compared to the 8-year average, GILD's PEG ratio stands 71% lower.
Why is Gilead Sciences's PEG ratio so low?
Strong earnings growth relative to valuation results in GILD's low PEG ratio of 0.32.
How is GILD's PEG ratio calculated (Gilead Sciences PEG ratio formula)?
The PEG ratio derives from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Jul 13, 2026, Gilead Sciences has a PE ratio of 17.71. Earnings grew at 55.6% over the TTM period ending Mar 2026. Applying the formula, this gives a PEG ratio of 0.32. PEG RATIO(0.32) = PE RATIO(17.71) / EPS GROWTH(55.6%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.